Catalyst Wire Dossier Catalyst Wire Dossier

GK Activator (2)

· Hoffmann-La Roche
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for GK Activator (2), covering 2016-08-24 to 2016-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of GK Activator (2) in Patients With Type 2 Diabetes Mellitus Treated With a Stable Dose of Metformin [Phase 2]

See pricing